MONTREAL, March 6, 2015 /CNW/ - DMD Digital Health Connections Group Inc. ("DMD" or the "Company") is pleased to announce that it has converted an aggregate amount of $360,850 owing to certain insiders into a total of 6,014,167 common shares at a price of $0.06 each. These shares will be subject to a four-month hold period from the date of closing. The closing of this transaction is subject to, among other things, final acceptance from the TSX Venture Exchange.
About DMD Digital Health Connections Group Inc.
DMD enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Top pharmaceutical companies, agencies and respected healthcare organizations have adopted DMD's solutions to target, engage and interact with leading healthcare practitioners. For more information, visit www.dmdconnects.com .
Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE DMD Digital Health Connections Group Inc.
For further information: André Charron, CFO, DMD Digital Health Connections Group Inc., 514-769-5858, ACharron@dmdconnects.com